Odey Holdings (Switzerland)’s Alexion Pharmaceuticals ALXN Stock Holding History

Odey Holdings (Switzerland)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,660	Closed	-$217K	–	18
2019 Q2	$217K	Buy	1,660 +1,200	+261%	+$155K	2.76%	7
2019 Q1	$62K	Hold	460	–	–	0.78%	10
2018 Q4	$45K	Hold	460	–	–	3.15%	22
2018 Q3	$64K	Hold	460	–	–	3.42%	16
2018 Q2	$57K	Hold	460	–	–	3.72%	13
2018 Q1	$51K	Hold	460	–	–	4.03%	12
2017 Q4	$55K	Hold	460	–	–	3.36%	11
2017 Q3	$65K	Hold	460	–	–	4.26%	11
2017 Q2	$56K	Buy	+460	New	+$53.5K	4.04%	11
2016 Q4	–	Sell	-425	Closed	-$52K	–	24
2016 Q3	$52K	Buy	+425	New	+$54.7K	2.27%	21

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Odey Holdings (Switzerland)'s ALXN Position: Q3 2019 in Review

Odey Holdings (Switzerland) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 1,660 shares — an estimated $217K sold.

Odey Holdings (Switzerland) first reported a position in ALXN in Q3 2016 and held it in 10 quarters. The position peaked at $217K in Q2 2019. 647 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

Odey Holdings (Switzerland) reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Odey Holdings (Switzerland) sold 1,660 Alexion Pharmaceuticals shares in Q3 2019, an estimated $217K.
Odey Holdings (Switzerland) first reported a position in Alexion Pharmaceuticals in Q3 2016 and held it in 10 quarters.
Odey Holdings (Switzerland)'s Alexion Pharmaceuticals position peaked at $217K in Q2 2019.
647 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Odey Holdings (Switzerland)'s 13F filing for Q3 2019, filed 14 Nov 2019.